Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia

NCT00080496 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Pneumonia

Interventions

DRUG: Tigecycline
DRUG: Imipenem
DRUG: Cilastatin

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer